Subependymal giant cell astrocytoma medical therapy: Difference between revisions

Jump to navigation Jump to search
Sujit Routray (talk | contribs)
No edit summary
Sujit Routray (talk | contribs)
Line 7: Line 7:
==Medical Therapy==
==Medical Therapy==


The treatment options for pilocytic astrocytoma include the following:<ref name="SievertFisher2009">{{cite journal|last1=Sievert|first1=A. J.|last2=Fisher|first2=M. J.|title=Pediatric Low-Grade Gliomas|journal=Journal of Child Neurology|volume=24|issue=11|year=2009|pages=1397–1408|issn=0883-0738|doi=10.1177/0883073809342005}}</ref><ref name=RxPA1>Treatment Option Overview for Childhood Astrocytomas. National Cancer Institute 2015. http://www.cancer.gov/types/brain/hp/child-astrocytoma-treament-pdq#section/_35. Accessed on October 30, 2015</ref>
The treatment options for subependymal giant cell astrocytoma include the following:<ref name="pmid23391693">{{cite journal| author=Jóźwiak S, Nabbout R, Curatolo P, participants of the TSC Consensus Meeting for SEGA and Epilepsy Management| title=Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations. | journal=Eur J Paediatr Neurol | year= 2013 | volume= 17 | issue= 4 | pages= 348-52 | pmid=23391693 | doi=10.1016/j.ejpn.2012.12.008 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23391693  }} </ref>





Revision as of 20:30, 4 November 2015

Subependymal giant cell astrocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Subependymal Giant Cell Astrocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Subependymal giant cell astrocytoma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Subependymal giant cell astrocytoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Subependymal giant cell astrocytoma medical therapy

CDC on Subependymal giant cell astrocytoma medical therapy

Subependymal giant cell astrocytoma medical therapy in the news

Blogs on Subependymal giant cell astrocytoma medical therapy

Directions to Hospitals Treating Ependymoma

Risk calculators and risk factors for Subependymal giant cell astrocytoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Medical Therapy

The treatment options for subependymal giant cell astrocytoma include the following:[1]


 
 
 
 
 
 
 
 
Treatment of subependymal giant cell astrocytoma
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surgery
 
 
 
 
Gamma knife radiosurgery
 
 
 
 
Chemotherapy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rapamycin
 
Everolimus

Reference

  1. Jóźwiak S, Nabbout R, Curatolo P, participants of the TSC Consensus Meeting for SEGA and Epilepsy Management (2013). "Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations". Eur J Paediatr Neurol. 17 (4): 348–52. doi:10.1016/j.ejpn.2012.12.008. PMID 23391693.


Template:WikiDoc Sources